CEACAM5 and neoplasm: Next, we characterized patients with elevated CEA/CA19-9 by analyzing the mRNA expression profiles of tumor tissues before NACT in 63 patients, including 50 and 13 patients with initial normal and elevated CEA/CA19-9, respectively.